These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 11828838

  • 1. Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records.
    van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A.
    Pharmacoepidemiol Drug Saf; 2001; 10(6):549-54. PubMed ID: 11828838
    [Abstract] [Full Text] [Related]

  • 2. Population prevalence and incidence of Parkinson's disease in an Australian community.
    Mehta P, Kifley A, Wang JJ, Rochtchina E, Mitchell P, Sue CM.
    Intern Med J; 2007 Dec; 37(12):812-4. PubMed ID: 17561942
    [Abstract] [Full Text] [Related]

  • 3. Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment.
    van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A.
    Eur J Clin Pharmacol; 2002 May; 58(2):157-61. PubMed ID: 12012150
    [Abstract] [Full Text] [Related]

  • 4. Dynamics of parkinsonism-Parkinson's disease in residents of adjacent kibbutzim in Israel's Negev.
    Goldsmith JR, Herishanu YO, Podgaietski M, Kordysh E.
    Environ Res; 1997 May; 73(1-2):156-61. PubMed ID: 9311541
    [Abstract] [Full Text] [Related]

  • 5. [Estimation of the prevalence of Parkinson's disease in Asturia, Spain. A pharmacoepidemiological study of the consumption of antiparkinson drugs].
    Martínez-Suárez MM, Blázquez-Menes B.
    Rev Neurol; 1997 May; 31(11):1001-6. PubMed ID: 11190861
    [Abstract] [Full Text] [Related]

  • 6. Use of antiparkinsonian drugs in Denmark: results from a nationwide pharmacoepidemiological study.
    Brandt-Christensen M, Kvist K, Nilsson FM, Andersen PK, Kessing LV.
    Mov Disord; 2006 Aug; 21(8):1221-5. PubMed ID: 16671076
    [Abstract] [Full Text] [Related]

  • 7. [The estimation of prevalence of Parkinson disease in Navarra. An epidemiological study of the consumption of anti-parkinsonian drugs].
    Artázcoz Sanz MT, Viñes Rueda JJ.
    Rev Esp Salud Publica; 1995 Aug; 69(6):479-85. PubMed ID: 8789360
    [Abstract] [Full Text] [Related]

  • 8. Prediction model of Parkinson's disease based on antiparkinsonian drug claims.
    Moisan F, Gourlet V, Mazurie JL, Dupupet JL, Houssinot J, Goldberg M, Imbernon E, Tzourio C, Elbaz A.
    Am J Epidemiol; 2011 Aug 01; 174(3):354-63. PubMed ID: 21606234
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prospective study of coffee consumption and risk of Parkinson's disease.
    Sääksjärvi K, Knekt P, Rissanen H, Laaksonen MA, Reunanen A, Männistö S.
    Eur J Clin Nutr; 2008 Jul 01; 62(7):908-15. PubMed ID: 17522612
    [Abstract] [Full Text] [Related]

  • 11. Levodopa-dyskinesia incidence by age of Parkinson's disease onset.
    Kumar N, Van Gerpen JA, Bower JH, Ahlskog JE.
    Mov Disord; 2005 Mar 01; 20(3):342-4. PubMed ID: 15580606
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of Parkinson's disease and related disorders in the elderly population of greater Beijing, China.
    Zhang ZX, Anderson DW, Huang JB, Li H, Hong X, Wei J, Yang EL, Maraganore DM.
    Mov Disord; 2003 Jul 01; 18(7):764-72. PubMed ID: 12815655
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of a refined drug tracer algorithm to estimate prevalence and incidence of Parkinson's disease in a large israeli population.
    Chillag-Talmor O, Giladi N, Linn S, Gurevich T, El-Ad B, Silverman B, Friedman N, Peretz C.
    J Parkinsons Dis; 2011 Jul 01; 1(1):35-47. PubMed ID: 23939255
    [Abstract] [Full Text] [Related]

  • 18. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.
    Mirandola M, Andretta M, Corbari L, Sorio A, Nosè M, Barbui C.
    Pharmacoepidemiol Drug Saf; 2006 Jun 01; 15(6):412-20. PubMed ID: 16287199
    [Abstract] [Full Text] [Related]

  • 19. Incidence and mortality of Parkinson's disease in older Canadians.
    Allyson Jones C, Wayne Martin WR, Wieler M, King-Jesso P, Voaklander DC.
    Parkinsonism Relat Disord; 2012 May 01; 18(4):327-31. PubMed ID: 22197034
    [Abstract] [Full Text] [Related]

  • 20. Estimating prevalence, incidence, and disease-related mortality for patients with epilepsy in managed care organizations.
    Holden EW, Thanh Nguyen H, Grossman E, Robinson S, Nelson LS, Gunter MJ, Von Worley A, Thurman DJ.
    Epilepsia; 2005 Feb 01; 46(2):311-9. PubMed ID: 15679513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.